MRNA250103C31000
- 0.00
- 0.000.00%
Moderna Newsroom
Express News | Moderna CEO Letter Says With A Full Season Of RSV Contracting In 2025, Expect To Increase MRESVIA's Market Share In U.S. And Market Access Globally; Plan To Bring Manufacturing Plants Online In The UK, Canada And Australia In 2025
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
Vaccine Stocks Gain Amid Uptick in Flu, COVID-19, RSV
Moderna Targets 10 New Approvals by 2027
Express News | Moderna Shares up 3.8% Premarket
Moderna (MRNA) Rises But Trails Market: What Investors Should Know
Moderna Options Spot-On: On January 3rd, 117.68K Contracts Were Traded, With 657.56K Open Interest
Unusual Options Activity: PG, DAL and Others Attract Market Bets, PG V/OI Ratio Reaches 133.3
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
The S&P 500's 10 Worst Performing Stocks in 2023 Fell Again in 2024
Best and Worst Performing S&P 500 Stocks in a Rosy Year for Index
Santa Claus Came Without Rallying the Troops | Live Stock
Moderna Options Spot-On: On January 2nd, 112.55K Contracts Were Traded, With 646.17K Open Interest
These Battered S&P 500 Stocks Could Be Ripe for a Turnaround in 2025
Why Moderna Inc. (MRNA) Is Skyrocketing
Equity Markets Fall Intraday as 2024 Draws to Close
Peering Into Moderna's Recent Short Interest
These Stocks Are Moving the Most Today: Super Micro, Moderna, Nvidia, MicroStrategy, Palantir, VeriSign, Sangamo, and More -- Barrons.com